Skyhawk Therapeutics
An Associate Director/Director, Commercial Project Management at Skyhawk Therapeutics leads cross-functional planning and execution for the launch of SKY-0515, a disease-modifying therapy for Huntington's disease. The role involves driving launch readiness, coordinating across teams, and managing complex project management infrastructure.
Headquarters
Waltham, Massachusetts, United States
Company Size
51-200 employees
Founded
2016
Skyhawk Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing RNA-targeting small molecules to treat serious diseases. Its SKYSTAR platform enables rapid discovery of RNA-modulating compounds across neurology, oncology, and fibrotic diseases, with programs such as SKY-0515 for Huntington's disease and collaborations with major pharmaceutical partners.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Skyhawk Therapeutics.
34% above the average for this role
Director, Business & Operations – US Affiliate
Dyne Therapeutics
Director, Pipeline Commercial Strategy - Immunology
AbbVie
Director, Business Strategy & Operations - Commercialization
Dyne Therapeutics
Senior Director, Metabolic Market Access Strategy & Marketing
Travere Therapeutics
Director, Patient Advocacy
Zevra
Sales Specialist
ExecuSearch of Chicago